Cargando…

Morphoproteomic-Guided Host-Directed Therapy for Tuberculosis

In an effort to develop more effective therapy for tuberculosis (TB), research efforts are looking toward host-directed therapy, reprograming the body’s natural defenses to better control the infection. While significant progress is being made, the efforts are limited by lack of understanding of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Robert E., Hunter, Robert L., Hwang, Shen-An
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288338/ https://www.ncbi.nlm.nih.gov/pubmed/28210262 http://dx.doi.org/10.3389/fimmu.2017.00078

Ejemplares similares

Refractory Hydroa Vacciniforme-like Lymphoma: Biological Insights from Morphoproteomic Analysis
por: Goswamy, Rohit, et al.
Publicado: (2022)

Host-Directed Therapy in Tuberculosis: Targeting Host Metabolism
por: Kim, Jae-Sung, et al.
Publicado: (2020)

Granulomas and Inflammation: Host-Directed Therapies for Tuberculosis
por: Ndlovu, Hlumani, et al.
Publicado: (2016)

Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis
por: Krug, Stefanie, et al.
Publicado: (2021)

Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis
por: Abreu, Rodrigo, et al.
Publicado: (2020)

Are There Sex-Specific Differences in Response to Adjunctive Host-Directed Therapies for Tuberculosis?
por: Dutta, Noton K., et al.
Publicado: (2020)

Early Lesion of Post-Primary Tuberculosis: Subclinical Driver of Disease and Target for Vaccines and Host-Directed Therapies
por: Brown, Robert E., et al.
Publicado: (2021)

The Manipulation of the Lipid Mediator Metabolism as Adjunct Host-Directed Therapy in Tuberculosis
por: Nienaber, Arista, et al.
Publicado: (2021)

Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection
por: Pires, David, et al.
Publicado: (2021)

Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis
por: Guler, Reto, et al.
Publicado: (2021)

Morphoproteomics and biomedical analytics coincide with clinical outcomes in supporting a constant but variable role for the mTOR pathway in the biology of congenital hyperinsulinism of infancy
por: Brown, Robert E., et al.
Publicado: (2017)

Mycobacterium tuberculosis Infection-Driven Foamy Macrophages and Their Implications in Tuberculosis Control as Targets for Host-Directed Therapy
por: Shim, Dahee, et al.
Publicado: (2020)

Corrigendum: Mycobacterium tuberculosis Infection-Driven Foamy Macrophages and Their Implications in Tuberculosis Control as Targets for Host-Directed Therapy
por: Shim, Dahee, et al.
Publicado: (2020)

Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures
por: Subbiah, Vivek, et al.
Publicado: (2011)

Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis
por: Palucci, Ivana, et al.
Publicado: (2020)

Monocyte and Macrophage miRNA: Potent Biomarker and Target for Host-Directed Therapy for Tuberculosis
por: Sampath, Pavithra, et al.
Publicado: (2021)

Morphoproteomics, E6/E7 in-situ hybridization, and biomedical analytics define the etiopathogenesis of HPV-associated oropharyngeal carcinoma and provide targeted therapeutic options
por: Brown, Robert E., et al.
Publicado: (2017)

Alveolar rhabdomyosarcoma: morphoproteomics and personalized tumor graft testing further define the biology of PAX3-FKHR(FOXO1) subtype and provide targeted therapeutic options
por: Brown, Robert E., et al.
Publicado: (2016)

Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review
por: Kroesen, Vera M., et al.
Publicado: (2017)

Stimulation through CD40 and TLR-4 Is an Effective Host Directed Therapy against Mycobacterium tuberculosis
por: Khan, Nargis, et al.
Publicado: (2016)

Host-Directed Therapies for Cutaneous Leishmaniasis
por: Novais, Fernanda O., et al.
Publicado: (2021)

Progressive Host-Directed Strategies to Potentiate BCG Vaccination Against Tuberculosis
por: Negi, Kriti, et al.
Publicado: (2022)

The Pathogenesis of Tuberculosis: The Early Infiltrate of Post-primary (Adult Pulmonary) Tuberculosis: A Distinct Disease Entity
por: Hunter, Robert L.
Publicado: (2018)

Applying Precision Medicine and Immunotherapy Advances from Oncology to Host-Directed Therapies for Infectious Diseases
por: Mahon, Robert N., et al.
Publicado: (2017)

Host-Directed Therapies for Tuberculosis
por: Jeong, Eui-Kwon, et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis
por: Leukes, Vinzeigh, et al.
Publicado: (2020)

Editorial: Host-Directed Therapies for Tuberculosis
por: Costa, Diego L., et al.
Publicado: (2021)

Host Directed Therapy Against Infection by Boosting Innate Immunity
por: Bergman, Peter, et al.
Publicado: (2020)

The New Frontier of Host-Directed Therapies for Mycobacterium avium Complex
por: Crilly, Nathan P., et al.
Publicado: (2021)

Modulation of innate immunity in airway epithelium for host-directed therapy
por: Myszor, Iwona T., et al.
Publicado: (2023)

Host-directed therapy for bacterial infections -Modulation of the phagolysosome pathway-
por: Taya, Toshihiko, et al.
Publicado: (2023)

Morphoproteomic Profiling of the Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Desmoplastic Small Round Cell Tumor (EWS/WT1), Ewing’s Sarcoma (EWS/FLI1) and Wilms’ Tumor(WT1)
por: Subbiah, Vivek, et al.
Publicado: (2013)

Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2017)

The Granuloma in Tuberculosis: Dynamics of a Host–Pathogen Collusion
por: Ehlers, Stefan, et al.
Publicado: (2013)

Evaluation of Host Serum Protein Biomarkers of Tuberculosis in sub-Saharan Africa
por: Morris, Thomas C., et al.
Publicado: (2021)

Mycobacterial Dormancy Systems and Host Responses in Tuberculosis
por: Peddireddy, Vidyullatha, et al.
Publicado: (2017)

Morphoproteomics and biomedical analytics confirm the mTORC2/Akt pathway as a resistance signature and activated ERK and STAT3 as concomitant prosurvival/antiapoptotic pathways in metastatic renal cell carcinoma (RCC) progressing on rapalogs: Pathogenesis and therapeutic options
por: Brown, Robert E., et al.
Publicado: (2016)

Vitamin D as Adjunctive Host-Directed Therapy in Tuberculosis: A Systematic Review
por: Wallis, Robert S., et al.
Publicado: (2016)

Potentials of Host-Directed Therapies in Tuberculosis Management
por: Dara, Yash, et al.
Publicado: (2019)

Manipulation of autophagy for host-directed tuberculosis therapy
por: Gina, P, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_le4l6n3d96uscdq96qgcsnfsdf